Y Morishima

7.9k total citations
235 papers, 6.0k citations indexed

About

Y Morishima is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Y Morishima has authored 235 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Hematology, 64 papers in Cardiology and Cardiovascular Medicine and 47 papers in Immunology. Recurrent topics in Y Morishima's work include Hematopoietic Stem Cell Transplantation (61 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Blood Coagulation and Thrombosis Mechanisms (36 papers). Y Morishima is often cited by papers focused on Hematopoietic Stem Cell Transplantation (61 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Blood Coagulation and Thrombosis Mechanisms (36 papers). Y Morishima collaborates with scholars based in Japan, United States and Germany. Y Morishima's co-authors include Yasufumi Shirasaki, Hiromichi Takano, Yuko Honda, Yukiko Gotoh, Janine Zieg, Roger J. Davis, Richard A. Flavell, Michael E. Greenberg, Tamera Barrett and Y Kodera and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Y Morishima

226 papers receiving 5.8k citations

Peers

Countries citing papers authored by Y Morishima

Since Specialization

Citations

This map shows the geographic impact of Y Morishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Morishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Morishima more than expected).

Fields of papers citing papers by Y Morishima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Morishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Morishima. The network helps show where Y Morishima may publish in the future.

Co-authorship network of co-authors of Y Morishima

This figure shows the co-authorship network connecting the top 25 collaborators of Y Morishima. A scholar is included among the top collaborators of Y Morishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Morishima. Y Morishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Coronary events in elderly patients with non-valvular atrial fibrillation: a prespecified sub-analysis of the ANAFIE registry 2024 ·Cardiovascular Intervention and Therapeutics ·Masato Nakamura, Hiroshi Inoue, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, Yukihiro Koretsune, Ken Okumura, Wataru Shimizu, Shinya Suzuki, Hiroyuki Tsutsui, Ḱazunori Toyoda, Masahiro Yasaka, Takenori Yamaguchi, Satoshi Teramukai, Y Morishima, M. Fukuzawa, Atsushi Takita, Atsushi Hirayama	2
2	Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study 2023 ·Cardiovascular Diabetology ·Yasuo Terauchi, Hiroshi Inoue, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, Yukihiro Koretsune, Ken Okumura, Shinya Suzuki, Hiroyuki Tsutsui, Ḱazunori Toyoda, Atsushi Hirayama, Masahiro Yasaka, Takenori Yamaguchi, Satoshi Teramukai, Tetsuya Kimura, Y Morishima, Atsushi Takita, Wataru Shimizu	3
3	Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　― ANAFIE Registry Sub-Analysis ― 2023 ·Circulation Journal ·Masaharu Akao, Hiroshi Inoue, Takeshi Yamashita, Hirotsugu Atarashi, Takanori Ikeda, Yukihiro Koretsune, Ken Okumura, Shinya Suzuki, Hiroyuki Tsutsui, Ḱazunori Toyoda, Atsushi Hirayama, Masahiro Yasaka, Takenori Yamaguchi, Satoshi Teramukai, Tetsuya Kimura, Y Morishima, Atsushi Takita, Wataru Shimizu	4
4	Home Blood Pressure Can Predict the Risk for Stroke/Bleeding Events in Elderly Patients With Nonvalvular Atrial Fibrillation From the ANAFIE Registry 2022 ·Hypertension ·Kazuomi Kario, Naoyuki Hasebe, Ken Okumura, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, Yukihiro Koretsune, Wataru Shimizu, Shinya Suzuki, Hiroyuki Tsutsui, Ḱazunori Toyoda, Atsushi Hirayama, Masahiro Yasaka, Takenori Yamaguchi, Satoshi Teramukai, Tetsuya Kimura, Y Morishima, Atsushi Takita, Hiroshi Inoue	7
5	Fibrinolytic potential of DS-1040, a novel orally available inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) 2018 ·Thrombosis Research ·(unknown), (unknown), Naoki Miyoshi, (unknown), Akiko Watanabe, Yusuke Ito, Y Morishima, Kyoji Yamaguchi	9
6	Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation 2013 ·Annals of Oncology ·Satoshi Nishiwaki, Koichi Miyamura, Kazuteru Ohashi, Mineo Kurokawa, Satoshi Taniguchi, Takahiro Fukuda, Kazuhiro Ikegame, Satoshi Takahashi, Takehiko Mori, Kiyotoshi Imai, Hiroatsu Iida, Michihiro Hidaka, Hisashi Sakamaki, Y Morishima, Koji Kato, Ritsuro Suzuki, Junji Tanaka	21
7	HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype 2012 ·Tissue Antigens ·(unknown), (unknown), Marie Bleakley, (unknown), Aiko Sato‐Otsubo, Hiroki Torikai, Takashi Hamajima, Yasuhito Nannya, Ayako Demachi‐Okamura, Etsuko Maruya, H. Saji, Yukiya Yamamoto, Takashi Takahashi, Nobuhiko Emi, Y Morishima, Y Kodera, Kiyotaka Kuzushima, Stanley R. Riddell, Seishi Ogawa, Yoshiki Akatsuka	4
8	Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809 2011 ·Annals of Oncology ·Ken Ohmachi, Kensei Tobinai, Yukio Kobayashi, Kuniaki Itoh, Masanobu Nakata, Taro Shibata, Y Morishima, Michinori Ogura, Takeshi Suzuki, Ryuzo Ueda, Kohsuke Aikawa, Shigeo Nakamura, Haruhiko Fukuda, M Shimoyama, T Hotta	25
9	Significant differences in outcome following unrelated donor HCT can be better predicted using an algorithm incorporating both allele and epitope level matching for HLA-DPB1 2009 ·UCL Discovery (University College London) ·(unknown), Katharina Fleischhauer, E. Zino, Mari Malkki, (unknown), Y Morishima, Ted Gooley, E.W. Petersdorf	1
10	DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles 2008 ·Journal of Thrombosis and Haemostasis ·Taketoshi Furugohri, K. Isobe, Yuko Honda, (unknown), Nobutoshi Sugiyama, Takayasu Nagahara, Y Morishima, Toshiro Shibano	246
11	Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505 2002 ·Annals of Oncology ·Kuniaki Itoh, T. Ohtsu, Haruhiko Fukuda, Yusuke Sasaki, Michinori Ogura, Y Morishima, Ting‐Chao Chou, Kohsuke Aikawa, Naokuni Uike, (unknown), Tatsuharu Ohno, Shu‐ichi Ikeda, (unknown), Masafumi Taniwaki, (unknown), Miyuki Niimi, T Hotta, M Shimoyama, Kensei Tobinai	44
12	AML M0.の明確なサブタイプである骨髄/NK前駆細胞急性白血病 2001 ·Blood ·Ritsuro Suzuki, Makoto Murata, Masahiro Kami, Shigeki Ohtake, Norio Asou, Yasuo Kodera, (unknown), Nobuyuki Hamajima, Manabu Shimoyama, (unknown), Y Morishima, Shohei Nakamura	2
13	Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation 2001 ·Bone Marrow Transplantation ·Atae Utsunomiya, Yasushi Miyazaki, Y Takatsuka, Shuichi Hanada, K Uozumi, Shinji Yashiki, Mitsutoshi Tara, Fumio Kawano, Yoshio Saburi, Hiroshi Kikuchi, Masamichi Hara, Hiroshi Sao, Y Morishima, Y Kodera, Shunro Sonoda, Masao Tomonaga	181
14	Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation 2000 ·Bone Marrow Transplantation ·Keitaro Matsuo, Nobuyuki Hamajima, Y Morishima, M Harada	21
15	Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation 1999 ·Bone Marrow Transplantation ·Shuichi Mizuta, Yoshiaki Ito, A Kohno, Hitoshi Kiyoi, Koichi Miyamura, Mitsune Tanimoto, Junki Takamatsu, T Naoe, Y Morishima, Ryuzo Ueda, Hidehiko Saito, (unknown)	17
16	Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma 1998 ·Annals of Oncology ·Kensei Tobinai, Yukio Kobayashi, Masaru Narabayashi, Michinori Ogura, Yoshitoyo Kagami, Y Morishima, T. Ohtsu, Tomofumi Igarashi, Yosuke Sasaki, T. Kinoshita, Takashi Murate	126
17	N-3 vs N-6 POLYUNSATURATED FATTY ACIDS (PUFA) IN CRITICAL ILLNESS 1997 ·Tsuguhiko Tashiro, Hideo Yamamori, Naganori Hayashi, Katsunori Furukawa, Y Morishima, Takahiro Sugiura, (unknown), Wataru Sano, Yu Toyoda, Hiroshi Nitta, (unknown), (unknown), Nobuyuki Nakajima	0
18	Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG). 1992 ·PubMed ·R Ohno, Toshiyuki Kobayashi, Y Morishima, A Hiraoka, Kenichiro Imai, Norichika Asoh, Kazuo Tsubaki, Masao Tomonaga, Isao Takahashi, (unknown)	12
19	Solubilization and Characterization of Substance P Binding Protein from Bovine Brainstem 1988 ·Journal of Neurochemistry ·Yoshihiro Nakata, Hiroyasu Tanaka, Y Morishima, Tomio Segawa	21
20	Acute lymphoblastic leukaemia of the B-cell type refractory to intensive chemotherapy. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Koichiro Kawashima, Y Morishima, Yoshiro Kato, (unknown), Masashi Kobayashi, Keiji Suzuki, (unknown), Koichi Yamada, (unknown), Satoshi Yoshikawa, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact